Immuneering (IMRX) Share-based Compensation (2020 - 2026)
Immuneering's Share-based Compensation was $2.06 million in Q3 2026, up 41.5% from $1.46 million a year earlier and up 26.6% from the prior quarter.
Powered by 
Analysis
Immuneering (IMRX) Share-based Compensation (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immuneering's Share-based Compensation was $6.96 million through Sep 30, 2026, up 8.8% year-over-year; for FY2025, it came in at $6.31 million, down 2.9% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 42.2% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $6.5 million in FY2024 (+13.5%), $5.73 million in FY2023 (+40.9%), $4.06 million in FY2022 (+125.5%) and $1.8 million in FY2021 (+65.9%).
- The Q3 2026 figure marks the highest quarterly Share-based Compensation in data going back to Q2 2020.
- Compared with a year earlier, Share-based Compensation was higher in four of the last eight quarters, with growth averaging 5.0%.
- The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 392.6%); the worst was Q3 2025 (a decline of 11.2%).
- Per Business Quant data, IMRX's Share-based Compensation in the three quarters before Q3 2026 was $1.63 million (Q2 2026), $1.64 million (Q1 2026) and $1.64 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Immuneering | 246.36 Mn | -378.47 Mn | - | 2.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.06 Mn |
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | 1.72 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.05 Mn |
| Mar 31, 2022 | 897,650.00 |
| Dec 31, 2021 | 632,583.00 |
API Access
Immuneering Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();